S100A1 and breast carcinoma: Deregulation of individual annexins and S100A proteins have been associated with malignant transformation [22–26], tumor invasion [27–29], metastasis, angiogenesis and drug resistance [20, 30, 31], the effect being dependent on breast cancer sub-type.